VERA
VERA
NASDAQ · Biotechnology

Vera Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$30.48
-1.49 (-4.66%)
As of Nov 5, 8:35 PM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 18 90%
Hold 2 10%
Sell 0 0%
Price Target
Analyst Price Target +210.4% upside
Low Target $72.50
Average Target $94.61
High Target $144.94
Current Price $30.48
Current
$30.48
Target
$94.61
$72.50 $94.61 avg $144.94
Scenario Analysis
Bear Case
$72.50
137.9%
Low target
Base Case
$94.61
+210.4%
Avg target
Bull Case
$144.94
+375.5%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$56.05
-45.6% from high
52-Week Low
$23.05
+32.2% from low
50-Day SMA
$31.83
-4.2% vs SMA
200-Day SMA
$36.73
-17.0% vs SMA
RSI (14)
62.6
Neutral
Target vs 52W High
$94.61
+68.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -10.6%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +116.4%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
 Hold 31 35% $149.45 -38.1%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
 Strong Buy 30 90% $142.91 -60.7%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -35.8%